Hruz PW - Search Results

1

The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications.

Flint OP, Noor MA, Hruz PW, Hylemon PB, Yarasheski K, Kotler DP, Parker RA, Bellamine A. Flint OP, et al. Among authors: hruz pw. Toxicol Pathol. 2009 Jan;37(1):65-77. doi: 10.1177/0192623308327119. Epub 2009 Jan 26. Toxicol Pathol. 2009. PMID: 19171928 Free PMC article. Review.

2

Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, Masur H, Meigs JB, Mulligan K, Reiss P, Samaras K; Working Group 1. Grunfeld C, et al. Circulation. 2008 Jul 8;118(2):e20-8. doi: 10.1161/CIRCULATIONAHA.107.189623. Epub 2008 Jun 19. Circulation. 2008. PMID: 18566314 Free PMC article. No abstract available.

3

Investigating the cellular targets of HIV protease inhibitors: implications for metabolic disorders and improvements in drug therapy.

Murata H, Hruz PW, Mueckler M. Murata H, et al. Among authors: hruz pw. Curr Drug Targets Infect Disord. 2002 Mar;2(1):1-8. doi: 10.2174/1568005024605882. Curr Drug Targets Infect Disord. 2002. PMID: 12462148 Review.

4

Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis.

DeBosch BJ, Heitmeier MR, Mayer AL, Higgins CB, Crowley JR, Kraft TE, Chi M, Newberry EP, Chen Z, Finck BN, Davidson NO, Yarasheski KE, Hruz PW, Moley KH. DeBosch BJ, et al. Among authors: hruz pw. Sci Signal. 2016 Feb 23;9(416):ra21. doi: 10.1126/scisignal.aac5472. Sci Signal. 2016. PMID: 26905426 Free PMC article.

5

Molecular mechanisms for insulin resistance in treated HIV-infection.

Hruz PW. Hruz PW. Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):459-68. doi: 10.1016/j.beem.2010.10.017. Best Pract Res Clin Endocrinol Metab. 2011. PMID: 21663839 Free PMC article. Review.

6

Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal.

Yan Q, Hruz PW. Yan Q, et al. Among authors: hruz pw. J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):398-403. doi: 10.1097/01.qai.0000176654.97392.c7. J Acquir Immune Defic Syndr. 2005. PMID: 16280693 Free PMC article.

7

HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4.

Hresko RC, Hruz PW. Hresko RC, et al. Among authors: hruz pw. PLoS One. 2011;6(9):e25237. doi: 10.1371/journal.pone.0025237. Epub 2011 Sep 23. PLoS One. 2011. PMID: 21966466 Free PMC article.

8

Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism.

Hruz PW, Murata H, Mueckler M. Hruz PW, et al. Am J Physiol Endocrinol Metab. 2001 Apr;280(4):E549-53. doi: 10.1152/ajpendo.2001.280.4.E549. Am J Physiol Endocrinol Metab. 2001. PMID: 11254460 Free article. Review.

9

Effects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice.

Vyas AK, Koster JC, Tzekov A, Hruz PW. Vyas AK, et al. Among authors: hruz pw. J Biol Chem. 2010 Nov 19;285(47):36395-400. doi: 10.1074/jbc.M110.176321. Epub 2010 Sep 23. J Biol Chem. 2010. PMID: 20864532 Free PMC article.

10

GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system.

Hruz PW, Yan Q, Tsai L, Koster J, Xu L, Cihlar T, Callebaut C. Hruz PW, et al. Antimicrob Agents Chemother. 2011 Apr;55(4):1377-82. doi: 10.1128/AAC.01184-10. Epub 2011 Jan 18. Antimicrob Agents Chemother. 2011. PMID: 21245443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters